Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Philippe Horello"'
Autor:
Philippe Horellou, Aliénor de Chalus, Laetitia Giorgi, Carole Leroy, Pascale Chrétien, Salima Hacein-Bey-Abina, Christine Bourgeois, Xavier Mariette, Ché Serguera, Roger Le Grand, Kumaran Deiva
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundMyelin oligodendrocytes glycoprotein (MOG) antibody-associated disease (MOGAD) represent 25% of pediatric acquired demyelinating syndrome (ADS); 40% of them may relapse, mimicking multiple sclerosis (MS), a recurrent and neurodegenerative A
Externí odkaz:
https://doaj.org/article/ad8652ab093d42bda4c0be6345f30bc4
Autor:
Che Serguera, Lev Stimmer, Claire-Maelle Fovet, Philippe Horellou, Vanessa Contreras, Nicolas Tchitchek, Julie Massonneau, Carole Leroy, Audrey Perrin, Julien Flament, Philippe Hantraye, Joanna Demilly, Romain Marignier, Pascale Chrétien, Bert‘t Hart, Jean Boutonnat, Clovis Adam, Roger Le-Grand, Kumaran Deiva
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-14 (2019)
Abstract Background Autoantibodies against myelin oligodendrocyte glycoprotein (anti-MOG-Abs) occur in a majority of children with acquired demyelinating syndromes (ADS) and physiopathology is still under investigation. As cynomolgus macaques immuniz
Externí odkaz:
https://doaj.org/article/e1038794ee40410a885a01b24354e627
Autor:
Claire-Maëlle Fovet, Lev Stimmer, Vanessa Contreras, Philippe Horellou, Audrey Hubert, Nabila Seddiki, Catherine Chapon, Sabine Tricot, Carole Leroy, Julien Flament, Julie Massonneau, Nicolas Tchitchek, Bert A. 't Hart, Sandra Zurawski, Peter Klucar, Philippe Hantraye, Kumaran Deiva, Gerard Zurawski, SangKon Oh, Roger Le Grand, Ché Serguera
Publikováno v:
EBioMedicine, Vol 47, Iss , Pp 492-505 (2019)
Background: Autoimmune demyelinating diseases (ADD) are a major cause of neurological disability due to autoreactive cellular and humoral immune responses against brain antigens. A cure for chronic ADD could be obtained by appropriate immunomodulatio
Externí odkaz:
https://doaj.org/article/8dcb23ba52be4f9b83ca67c40e294427
Publikováno v:
Neurobiology of Disease, Vol 4, Iss 3, Pp 280-287 (1997)
Gene therapy is a potentially powerful approach to the treatment of neurological diseases. Neurotransmitter synthesizing enzymes and neurotrophic factors inhibiting neurodegenerative processes provide the basis for current development of gene therapy
Externí odkaz:
https://doaj.org/article/2b962e9f89a04d8988ce5006d985ca02
Autor:
Mikael Cohen, Anne Lepine, Françoise Durand-Dubief, Bertrand Audoin, Mar Tintoré, Eric Thouvenot, Jonathan Ciron, Romain Marignier, Anne Ruiz, Kumaran Deiva, Jérôme De Seze, Philippe Horello, Alvaro Cobo-Calvo, Alexis Montcuquet, Caroline Papeix, Hélène Zéphir, Romain Deschamps, Sandra Vukusic, Hélène Maurey, Nicolas Collongues, Elisabeth Maillart, Pierre Labauge, Bertrand Bourre, Pierre Meyer, Damien Biotti, Georgina Arrambide, Fabien Rollot, Xavier Ayrignac
Publikováno v:
Annals of Neurology
Annals of Neurology, In press, 89, pp.30-41. ⟨10.1002/ana.25909⟩
Annals of Neurology, Wiley, In press, ⟨10.1002/ana.25909⟩
Annals of Neurology, In press, 89, pp.30-41. ⟨10.1002/ana.25909⟩
Annals of Neurology, Wiley, In press, ⟨10.1002/ana.25909⟩
OBJECTIVE: The main objective was to compare clinical features, disease course, and myelin oligodendrocyte glycoprotein (MOG) antibody (Ab) dynamics between children and adults with MOG-Ab-associated disease (MOGAD). METHODS: This retrospective multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f47c483807260824001fd05764266cba
https://hal.science/hal-03029833
https://hal.science/hal-03029833
